Sorrento Therapeutics's market cap is currently $275.64K. The company's EPS TTM is $; its P/E ratio is ―; Sorrento Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 62.84M	$ 52.90M	$ 39.99M	$ 31.43M	$ 21.19M
Gross Profit	$ 29.39M	$ 39.87M	$ 30.05M	$ 19.20M	$ 11.12M
Operating Income	$ -504.31M	$ -368.05M	$ -201.53M	$ -195.18M	$ -129.48M
EBITDA	$ -539.93M	$ -435.99M	$ -275.69M	$ -308.39M	$ -147.10M
Net Income	$ -572.84M	$ -429.01M	$ -308.57M	$ -359.10M	$ -203.54M
Balance Sheet
Cash & Short-Term Investments	$ 49.98M	$ 126.88M	$ 56.46M	$ 22.52M	$ 168.63M
Total Assets	$ 472.84M	$ 694.82M	$ 535.82M	$ 557.63M	$ 674.73M
Total Debt	$ 134.50M	$ 237.58M	$ 169.39M	$ 290.78M	$ 233.29M
Net Debt	$ 110.87M	$ 200.91M	$ 112.93M	$ 268.26M	$ 64.96M
Total Liabilities	$ 494.51M	$ 616.69M	$ 395.09M	$ 524.88M	$ 467.23M
Stockholders' Equity	$ -18.61M	$ 78.75M	$ 165.15M	$ 78.59M	$ 209.47M
Cash Flow
Free Cash Flow	$ -307.51M	$ -290.69M	$ -197.12M	$ -184.44M	$ -132.96M
Operating Cash Flow	$ -293.86M	$ -281.82M	$ -159.54M	$ -173.00M	$ -111.77M
Investing Cash Flow	$ -28.52M	$ 79.85M	$ -39.92M	$ -38.17M	$ -21.20M
Financing Cash Flow	$ 311.72M	$ 181.33M	$ 174.24M	$ 78.89M	$ 326.00M

Currency in USD

Sorrento Therapeutics Earnings and Revenue History

Income Statement >

Sorrento Therapeutics Debt to Assets

Balance Sheet >

Sorrento Therapeutics Cash Flow

Cash Flow >

Sorrento Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing